Refresh
Company Presentation • 22 Jun 2024 05:00
Company Presentation • 09 May 2024 20:30
Company Presentation • 29 Feb 2024 21:30
Company Presentation • 20 Dec 2023 21:30
Company Presentation • 28 Nov 2023 21:30
ENTITY
Argenx SE (ARGX US)
Argenx SE (ARGX US)
42
Analysis
Health Care • Netherlands
argenx SE operates as a biotechnology company. The Company develops antibody based therapies for the treatment of severe autoimmune diseases and cancer. argenx serves customers in the Netherlands and Belgium.
more
x